• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by PharmAla Biotech

    PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA MDXXF
    PharmAla Launches MDMA Clinical Trial Tool for Researchers
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA MDXXF
    PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA MDXXF
    Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA MDXXF
    Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA MDXXF
    Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA MDXXF
    Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA MDXXF
    PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA
    PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA PMBHF
    PharmAla Begins Trading on OTCQB
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA PMBHF
    PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA PMBHF
    USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA PMBHF
    PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers ASX:VIT CSE:MDMA
    Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA
    Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
    From PharmAla Biotech
    Via GlobeNewswire
    Tickers CSE:MDMA CSE:MSET MSSTF
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.